Clinical Trials
This page showcases some of the various clinical trials that we have been involved with, bringing state of the art technologies and pioneering treatments to the people of New York’s Capital District and surrounding region.
We are currently enrolling patients in clinical trials with macular degeneration, diabetic retinopathy, macular edema and several other conditions. Upcoming studies, pending various approvals, will soon be enrolling patients with macular edema, uveitis, ocular inflammation, and other conditions.
Macular Degeneration
Tenaya
Age Related Macular Degeneration
Enrollment Closed
This trial involved: This trial involves an injection of one medication into the eye.
Rhine
Diabetic Macular Edema
Enrollment Closed
This trial involved: This trial involves an injection of one medication into the eye.
Gallego
Geographic Atrophy related to Macular Degeneration
Enrollment Closed
This trial involved:This trial involves an injection of one medication into the eye
OPH1001
Macular Degeneration
Completed
This trial involved:
- 2 drugs injected into an eye
A phase II study to evaluate the safety of anti-PDGF (E10030). Injections in addition to Lucentis.
ForeseeHome Device Study
Macular Degeneration
Completed
This trial involved:
- a non invasive home monitoring device
A non invasive device to detect conversion to neovascular AMN
Race
Macular Degeneration
Completed
This trial involved:
- 2 drugs injected into an eye
A phase I study to evaluate the safety of anti-Complement (AL-78898A) Injections in addition to Lucentis.
OPH3000
Macular Degeneration
Completed
This trial involved:
- 2 drugs injected into an eye
A phase I study to evaluate the safety of Volociximab. Injections in addition to Lucentis
Intravitreal Remicade
Macular Degeneration & Diabetic Retinopathy
Completed
This trial involved:
- a drug injected into an eye
A phase I-pilot study to evaluate the safety of intravitreal Remicade (Infliximab). Injections for patients with severe diabetic macular edema or choroidal neovascularization.
OPH1000
Macular Degeneration
Completed
This trial involved:
- 2 drugs injected into an eye
A phase I study to evaluate the safety of anti-PDGF. Injections in addition to Lucentis
View 1
Wet Macular Degeneration
Completed
This trial involved:
- a drug injected into an eye
Phase 3 study to evaluate the VEGF Trap for wet Macular Degeneration
AREDS2
Dry Macular Degeneration
Completed
This trial involved:
- lutein, zeaxanthin, omega-3 fatty acids
Prevention of age related macular degeneration and cataracts with vitamin supplementation.
Sponsored by the National Institute of Health.
Salvage
Macular Degeneration
Completed
This trial involved:
- a drug injected into an eye
A phase I/II study to evaluate Scotoma reduction and Limited Visual Acuity in a GE related macular degeneration.
Patients treated with LUCENTIS.
HORIZON FVF3426
Macular Degeneration
Completed
This trial involved:
- a drug injection into an eye
Open label extension study with LUCENTIS (rhuFab V2). Therapy for Anchor and Marina patients.
Sailor
Macular Degeneration
Completed
This trial involved:
- a drug injected into an eye
Open label study with LUCENTIS (rhuFab V2). Therapy for Age Related Macular Degeneration
Marina
Macular Degeneration
Completed
This trial involved:
- a drug injected into an eye
- a drug injected to an arm vein
- laser treatment to the eye
Ranibizumab (rhuFab V2). Therapy for patients with Minimally Classic Subfoveal Choroidal Neovascular Membranes secondary to Macular Degeneration.
Anchor
Macular Degeneration
Completed
This trial involved:
- a drug injected into an eye
- a drug injected into an arm vein
- laser treatment to the eye
Ranibixumab (rhuFab V2) or Verteporfin (visudyne). Therapy for Patients with Mostly Classical Subfoveal Choroidal Neovascular Membranes secondary to Macular Degeneration.
Pfizer
Macular Degeneration
Completed
This trial involved:
- a drug injected next to the eye
Phase I anti-VEGF therapy. Subfoveal Choroidal Neovascular Membranes secondary to Macular Degeneration.
Eyetech
Macular Degeneration
Completed
This trial involved:
- a drug injected into the eye
Macugen Compassionate Use for Patients with Wet Macular Degeneration.
Vio
Macular Degeneration
Completed
This trial involved:
- a drug injected into an arm vein
- laser treatment to the eye
Vereporfin (Visudyne). Therapy for Patients with Entirely Occult Subfoveal Choroidal Neovascular Membranes secondary to Macular Degeneration.
ADD-V
Macular Degeneration
Completed
This trial involved:
- a drug injected into an arm vein
- eye drops
Vereporfin (Visudyne) and Voltaren drops. Therapy for Patients with Subfoveal Choroidal Neovascular Membranes secondary to Macular Degeneration.
Genentech/ROCHE Study
Wet Macular Degeneration
Enrollment Closed
This trial involves:
- a drug injected into the eye
Phase II Study to evaluate effectiveness of anti-VEGF vs. Lucentis
Hawk
Wet Macular Degeneration
Enrollment Closed
This trial involves:
- a drug injected into the eye
A Phase III Study to evaluate longevity of anti-VEGF vs. Eylea
Uveitis
Insure
Noninfectious Intermediate, Posterior or Panuveitis
Completed
This trial involved:
- a drug injected into the vein
Dose-ranging phase III trial to assess a monoclonal antibodies to IL 17 (IN457 vs. Placebo)
Sanofi
Non-infectious, Intermediate, Posterior or Pan-Uveitis
Completed
This trial involved:
- one drug injected subcutaneously
Phase II study to determine the efficacy of injectable subcutaneous drug.
AIN457
Non-infectious Uveitis
Completed
This trial involved:
- a drug injected into in the vein
Phase 2 study to evaluate monoclonal antibodies to IL 17 for uveitis
Peachtree
Non-infectious uveitis with Macular Edema
Completed
Novermber 2015
This trial involved:
- one drug injected into the eye
Phase III study to determine efficacy of Triamcinolone Acetonide Injectable Suspension
pSivida
Chronic Non-infectious Uveitis
Completed
November 2014
This trial involved:
- one implant placed in the eye
A Phase III study to evaluate safety and efficacy of a Fluocinolone Acetonide Intravitreal insert
Diabetic Retinopathy
Intravitreal Remicade
Macular Degeneration & Diabetic Retinopathy
Completed
This trial involved:
- a drug injected into an eye
A phase I/pilot study to evaluate the safety of intravitreal Remicade (Infliximab) Injections
Rise FVF4168g
Diabetic Retinopathy
Enrollment Closed
This trial involves:
- an oral drug taken daily
Intravitreal injections of Ranibizumab administered monthly for 24 months for patients with Diabetic Macular Edema
RXXANT B7A-MC-MBCU
Diabetic Retinopathy
Completed
This trial involved:
- a drug injected into the eye
Intravitreal Steroid for diabetic Macular Edema Laser for Diabetic Macular Edema
Central Retinal Vein Occlusion
Allergan
Retinal Vein Occlusions
Study Closed
This trial involved:
- a drug releasing implant injected into an eye
Intravitreal Steroid Implant for Vein Occlusions with Macular Edema
